SCHEMBL9853394

SCHEMBL9853394

CCCCc1nc2[nH]c(=O)n(CCCC)c(=O)c2n1CC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 13/20 0.45
ADORA3 P0DMS8 5/20 0.45
ADORA1 P30542 2/20 0.45
ADORA2A P29274 3/20 0.43
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
MEN1 O00255 2/20 0.43
RGS12 O14924 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
BLM P54132 1/20 0.39
CACNA1B Q00975 1/20 0.39
APBA1 Q02410 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9853392 0.81 MEN1 (0.53) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL10696644 0.77 ADORA2B (0.65) ADORA2BADORA3ADORA1ADORA2APDE4A
SCHEMBL7320101 0.75 MEN1 (0.52) MEN1KMT2AKDM4ENPC1ALDH1A1
SCHEMBL12152136 0.75 PDE4A (0.40) ADORA2BADORA3ADORA1ADORA2APDE4A
SCHEMBL8914154 0.71 MEN1 (0.57) MEN1KMT2AKDM4ENPC1ALDH1A1
SCHEMBL3848063 0.70 ADORA2B (0.60) ADORA2BADORA3ADORA1ADORA2APDE4A
SCHEMBL4445212 0.69 KDM4E (0.51) ADORA2BADORA3ADORA2APDE4APDE4B
SCHEMBL5867203 0.69 TSHR (0.48) MEN1KMT2AUSP2ALDH1A1POLB
SCHEMBL837200 0.68 ADORA2B (0.45) ADORA2BADORA3ADORA1ADORA2APDE4A
SCHEMBL23202393 0.67 MEN1 (0.47) ADORA2BADORA3ADORA1ADORA2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4965271-A Method of inhibiting the activity of leukocyte derived cytokines HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) 1990-10-23 US claimed
EP-0421587-A2 Xanthine derivatives used in asthma Beecham Group p.l.c. (GB) 1991-04-10 EP disclosed